Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

ClinicalTrials.gov ID: NCT00309959

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00309959. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial is studying how well ABI-007 works in treating patients with persistent or recurrent cervical cancer. Drugs used in chemotherapy, such as ABI-007, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Study identification

NCT ID
NCT00309959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
37 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Feb 2011 (Actual)
Completion
Not listed
Last update posted
Jan 8, 2019

Started 2006

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045 —
Rush University Medical Center Chicago Illinois 60612 —
Carle Clinic-Urbana Main Urbana Illinois 61801 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
Iowa Oncology Research Association CCOP Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates-Des Moines Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates-Laurel Des Moines Iowa 50314 —
Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
Iowa Lutheran Hospital Des Moines Iowa 50316 —
Mercy Hospital Springfield Springfield Missouri 65804 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Cooper Hospital University Medical Center Camden New Jersey 08103 —
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Mount Holly New Jersey 08060 —
Virtua West Jersey Hospital Voorhees Voorhees Township New Jersey 08043 —
Women's Cancer Care Associates LLC Albany New York 12208 —
University of North Carolina Chapel Hill North Carolina 27599 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Lake University Ireland Cancer Center Mentor Ohio 44060 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Tulsa Cancer Institute Tulsa Oklahoma 74146 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Lyndon Baines Johnson General Hospital Houston Texas 77026-1967 —
M D Anderson Cancer Center Houston Texas 77030 —
Carilion Clinic Gynecological Oncology Roanoke Virginia 24016 —
Saint Vincent Hospital Green Bay Wisconsin 54301 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00309959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2019 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.